AI-generated summary
The authors retrospectively reviewed five patients with central serous chorioretinopathy treated with micropulse laser photocoagulation, with a mean follow-up of 17.1 months. Four patients had complete resolution of symptoms, while one had recurrent disease that did not resolve after repeat treatment despite symptom improvement. The authors describe the results as supporting long-term efficacy, though the small, uncontrolled case series limits how far this can be generalized.
- Participants
- 5
- Who or what was studied
- Five patients with central serous chorioretinopathy
- Limits stated in the abstract
- Retrospective case series of only five patients without a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Retina. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.